Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Infect Control Hosp Epidemiol. 2013 Feb;34(2):171-5. doi: 10.1086/669082. Epub 2012 Dec 13.
Many bloodstream infections (BSIs) occurring in patients with febrile neutropenia following cytotoxic chemotherapy are due to translocation of intestinal microbiota. However, these infections meet the National Healthcare Safety Network (NHSN) definition of central line-associated BSIs (CLABSIs). We sought to determine the differences in the microbiology of NHSN-defined CLABSIs in patients with and without neutropenia and, using these data, to propose a modification of the CLABSI definition.
Retrospective review.
Two large university hospitals over 18 months.
All hospital-acquired BSIs occurring in patients with central venous catheters in place were classified using the NHSN CLABSI definition. Patients with postchemotherapy neutropenia (500 neutrophils/mm(3) or lower) at the time of blood culture were considered neutropenic. Pathogens overrepresented in the neutropenic group were identified to inform development of a modified CLABSI definition.
Organisms that were more commonly observed in the neutropenic group compared with the nonneutropenic group included Escherichia coli (22.7% vs 2.5%; P < .001) but not other Enterobacteriaceae, Enterococcus faecium (18.2% vs 6.1%; P = .002), and streptococci (18.2% vs 0%; P < .001). Application of a modified CLABSI definition (removing BSI with enterococci, streptococci, or E. coli) excluded 33 of 66 neutropenic CLABSIs and decreased the CLABSI rate in one study hospital with large transplant and oncology populations from 2.12 to 1.79 cases per 1,000 line-days.
Common gastrointestinal organisms were more common in the neutropenia group, suggesting that many BSIs meeting the NHSN criteria for CLABSI in the setting of neutropenia may represent translocation of gut organisms. These findings support modification of the NHSN CLABSI definition.
许多接受细胞毒性化疗后发生发热性中性粒细胞减少症的患者血流感染(BSI)是由于肠道微生物群的易位引起的。然而,这些感染符合国家医疗保健安全网络(NHSN)定义的中心静脉相关 BSI(CLABSI)。我们试图确定中性粒细胞减少症患者和非中性粒细胞减少症患者 NHSN 定义的 CLABSI 之间微生物学的差异,并使用这些数据提出 CLABSI 定义的修改。
回顾性研究。
18 个月内的两家大型大学医院。
使用 NHSN CLABSI 定义对所有发生在带有中央静脉导管的医院获得性 BSI 进行分类。在血液培养时中性粒细胞计数(500 个/毫米 3 或更低)的患者被认为是中性粒细胞减少症患者。确定中性粒细胞减少症组中过度表达的病原体,以告知开发修改后的 CLABSI 定义。
与非中性粒细胞减少症组相比,中性粒细胞减少症组更常见的病原体包括大肠杆菌(22.7%对 2.5%;P <.001),但非肠杆菌科、粪肠球菌(18.2%对 6.1%;P =.002)和链球菌(18.2%对 0%;P <.001)。应用改良的 CLABSI 定义(排除肠球菌、链球菌或大肠杆菌引起的 BSI)排除了 66 例中性粒细胞减少症 CLABSI 中的 33 例,并将一家大型移植和肿瘤科人群的研究医院的 CLABSI 发生率从每千条线路 1.79 例降低至每千条线路 1.79 例。
常见的胃肠道病原体在中性粒细胞减少症组中更为常见,这表明许多符合 NHSN 中性粒细胞减少症患者 CLABSI 标准的 BSI 可能代表肠道病原体的易位。这些发现支持 NHSN CLABSI 定义的修改。